This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Analysts' Actions: AGN AOS COG ETFC LLY


Air Lease (AL) was upgraded to hold at TheStreet Ratings.

Allergan (AGN) was upgraded at J.P. Morgan to overweight from neutral. Twelve-month price target is $190. Value in a potential transaction with Valeant, J.P. Morgan said.

AO Smith (AOS - Get Report) was upgraded to buy at Sterne Agee. Twelve-month price target is $58. Company boosted guidance once again, Sterne Agee said.

Must Read: Analysts' Actions: AGN FB HD NDAQ UA

AO Smith was upgraded at Wedbush to outperform from neutral. Twelve-month price target is $53. Growth outlook remains encouraging, Wedbush said.

AO Smith was upgraded at BMO Capital to outperform from market perform. Twelve-month price target is $57. China should continue to drive the company's growth, BMO Capital said.

AthenaHealth (ATHN) was upgraded at Morgan Stanley to overweight from equal-weight. Twelve-month price target is $192. See growth potential in both the core ambulatory business and expansion into the inpatient market, Morgan Stanley said.

Brown & Brown (BRO) was downgraded at Compass Point BRO was downgraded from Buy to Neutral, Compass Point said. $33 price target. Company could face near-term margin pressure.

Cabot (COG) was upgraded at Societe Generale to buy. Twelve-month price target is $43. Stock has lagged year-to-date, but fundamentals remain attractive, Societe Generale said.

Equifax (EFX) was upgraded at Credit Suisse to outperform from neutral. Twelve-month price target is $80. Organic revenue growth should accelerate, Credit Suisse said.

E*Trade (ETFC - Get Report) was upgraded at Wells Fargo to outperform from market perform. Bank should continue to generate excess capital, Wells Fargo said.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AOS $76.68 -0.62%
ETFC $24.86 -1.70%
AAPL $94.30 -0.92%
FB $118.08 0.55%
GOOG $695.81 0.50%


Chart of I:DJI
DOW 17,651.26 -99.65 -0.56%
S&P 500 2,051.12 -12.25 -0.59%
NASDAQ 4,725.6390 -37.5850 -0.79%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs